Generative AI is making significant strides in the life and health sciences sector, with new applications and developments emerging at a rapid pace. One of the key trends is the use of AI in protein design and engineering. Biotech start-up Cradle, for instance, recently raised $24 million in Series A funding to fast-track protein design using its AI-driven platform. The company's technology is not only speeding up the creation of enzymes, vaccines, and other biological products, but it's also addressing global health and environmental challenges. This development signifies a strategic expansion in the biotech sector, with Cradle's generative AI platform demonstrating its ability to double the pace of project progression compared to industry benchmarks.
